What is Sandhoff Disease

TL;DR: Sandhoff disease is a rare, progressive neurodegenerative disorder caused by a deficiency of the enzymes hexosaminidase A and B, leading to the toxic accumulation of fatty substances in the brain and other organs. Sandhoff disease typically presents in infancy with developmental regression and neurological decline, though rarer juvenile and adult-onset forms exist.

What is Sandhoff disease and how does it affect the body?

Sandhoff disease is a lysosomal storage disorder, meaning the body’s "recycling centers" (lysosomes) fail to break down specific fatty substances called GM2 gangliosides and globosides. Because these substances cannot be cleared away, they build up to toxic levels within the cells of the central nervous system and various organs, including the liver, spleen, and kidneys. As the brain cells become overwhelmed by these deposits, they gradually lose function, leading to the systemic neurological decline that characterizes Sandhoff disease.

What causes Sandhoff disease?

Sandhoff disease is caused by mutations in the HEXB gene, which provides instructions for making the beta-subunit of the hexosaminidase enzymes. Without functional hexosaminidase A and B, the body cannot process cellular waste. It is an autosomal recessive condition, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease. Parents of a child with Sandhoff disease are typically asymptomatic carriers, each having one mutated gene and one normal gene.

What are the different forms of Sandhoff disease?

The clinical presentation of Sandhoff disease is generally categorized by the age of onset, which correlates with the amount of residual enzyme activity:

• Infantile form: The most common and severe type, typically appearing at 3 to 6 months of age. Infants often show an exaggerated startle response, loss of motor skills, and vision loss.


• Juvenile form: Onset occurs in early to mid-childhood. Symptoms include ataxia (loss of coordination), cognitive decline, and speech difficulties.


• Adult-onset form: The rarest and mildest form, where symptoms may not appear until the second or third decade of life, often presenting as muscle weakness or psychiatric symptoms.

How common is Sandhoff disease?

Sandhoff disease is an extremely rare condition with an estimated global incidence of less than 1 in 100,000 live births. Unlike Tay-Sachs disease, which has a higher prevalence in specific ethnic populations, Sandhoff disease has been reported in diverse populations worldwide with no clear ethnic or geographic predilection. At DiseaseMaps.org, 44 people with Sandhoff disease have joined our community, reflecting the global reach and rarity of this diagnosis.

How does Sandhoff disease differ from other lysosomal disorders?

While Sandhoff disease is often compared to Tay-Sachs disease because both involve the GM2 ganglioside pathway, they are genetically distinct. In Tay-Sachs, only hexosaminidase A is deficient. Because Sandhoff disease involves a deficiency in both hexosaminidase A and B, the disease often results in additional systemic involvement, such as organomegaly (enlarged liver and spleen) and skeletal abnormalities, which are generally not present in classic Tay-Sachs.

Next steps

• Consult a metabolic specialist or a pediatric neurologist for clinical evaluation and confirmatory enzyme testing.


• Request a referral to a genetic counselor to discuss family planning and carrier testing for relatives.


• Join the DiseaseMaps.org community to connect with other families navigating the challenges of Sandhoff disease.


• Explore clinical trial databases such as ClinicalTrials.gov to stay informed about emerging research and therapeutic developments.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man): Entry #268800


• National Tay-Sachs & Allied Diseases Association (NTSAD)